Coronavirus: inside the ‘scrambled’ UK deal for five million Moderna vaccines
Fears over Trump’s ‘vaccine nationalism’ and European supplies led British ministers to prioritise other agreements
As news of another vaccine breakthrough emerged yesterday morning, ministers and civil servants rushed to finalise a deal to buy five million doses - at a cost of £95m.
Although the UK has secured 350 million doses of six Covid-19 jabs, most of which are still undergoing trials, “the Moderna vaccine is not one of those which the government has pre-ordered”, says The Spectator.
The reason, says The Times, is that “large-scale production of the Moderna vaccine is not expected in Europe until April”. As a result, “reaching agreement with other companies that can manufacture more rapidly was prioritised in the hope of starting mass immunisation before the year’s end”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A reluctance to deal with a US company amid “vaccine nationalism” and “concerns over unpredictable behaviour by the US president” also played a part, The Guardian reports. Ministers were reportedly concerned that Donald Trump might commandeer injections before they could be sent to the UK.
Finally, says Politico, the government “wanted to see the Phase 3 results before agreeing a deal”. When those results suggested that the vaccine was 95% effective, ministers and officials “hit Zoom and rushed through an agreement with Moderna”.
The last-minute response had led to “fears that Britain had missed out on supplies”, says The Guardian, especially as “the UK had also shunned the EU vaccine purchase scheme, arguing in July that the government could source vaccines faster on its own”.
That confidence appeared to be justified yesterday, when EU health commissioner Stella Kyriakides said she had “not yet concluded or signed a contract” with Moderna, although “negotiations with the company are ongoing”.
Aside from the Moderna jab, the UK has ordered 40 million doses of the 90% effective Pfizer/BioNTech vaccine - and 100 million doses of the Oxford/AstraZeneca vaccine candidate, which is still in Phase 3 trials.
Ministers “remain hopeful” that the Oxford jab “could be available soon - even by Christmas - with results of that trial reported to be imminent”, says The Guardian.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Holden Frith is The Week’s digital director. He also makes regular appearances on “The Week Unwrapped”, speaking about subjects as diverse as vaccine development and bionic bomb-sniffing locusts. He joined The Week in 2013, spending five years editing the magazine’s website. Before that, he was deputy digital editor at The Sunday Times. He has also been TheTimes.co.uk’s technology editor and the launch editor of Wired magazine’s UK website. Holden has worked in journalism for nearly two decades, having started his professional career while completing an English literature degree at Cambridge University. He followed that with a master’s degree in journalism from Northwestern University in Chicago. A keen photographer, he also writes travel features whenever he gets the chance.
-
7 beautiful towns to visit in Switzerland during the holidays
The Week Recommends Find bliss in these charming Swiss locales that blend the traditional with the modern
By Catherine Garcia, The Week US Published
-
The Week contest: Werewolf bill
Puzzles and Quizzes
By The Week US Published
-
'This needs to be a bigger deal'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
John Prescott: was he Labour's last link to the working class?
Today's Big Quesiton 'A total one-off': tributes have poured in for the former deputy PM and trade unionist
By Harriet Marsden, The Week UK Published
-
Last hopes for justice for UK's nuclear test veterans
Under the Radar Thousands of ex-service personnel say their lives have been blighted by aggressive cancers and genetic mutations
By Sorcha Bradley, The Week UK Published
-
Will Donald Trump wreck the Brexit deal?
Today's Big Question President-elect's victory could help UK's reset with the EU, but a free-trade agreement with the US to dodge his threatened tariffs could hinder it
By Harriet Marsden, The Week UK Published
-
What is the next Tory leader up against?
Today's Big Question Kemi Badenoch or Robert Jenrick will have to unify warring factions and win back disillusioned voters – without alienating the centre ground
By Harriet Marsden, The Week UK Published
-
What is Lammy hoping to achieve in China?
Today's Big Question Foreign secretary heads to Beijing as Labour seeks cooperation on global challenges and courts opportunities for trade and investment
By Harriet Marsden, The Week UK Published
-
Bob Woodward's War: the explosive Trump revelations
In the spotlight Nobody can beat Watergate veteran at 'getting the story of the White House from the inside'
By Chas Newkey-Burden, The Week UK Published
-
Trump kept up with Putin, sent Covid tests, book says
Speed Read The revelation comes courtesy of a new book by Bob Woodward
By Peter Weber, The Week US Published
-
'The federal government's response to the latest surge has been tepid at best'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published